Mangalam Drugs & Organics Limited (BOM:532637)

India flag India · Delayed Price · Currency is INR
30.27
+0.09 (0.30%)
At close: Jun 17, 2026
Market Cap479.12M -62.8%
Revenue (ttm)2.32B -26.9%
Net Income-444.00M
EPS-28.05
Shares Out 15.83M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6,082
Open30.18
Previous Close30.18
Day's Range29.58 - 30.55
52-Week Range22.70 - 94.80
Beta0.11
AnalystsStrong Buy
Price Target265.00 (+775.45%)
Earnings DateAug 10, 2026

About Mangalam Drugs & Organics

Mangalam Drugs & Organics Limited, together with its subsidiary, manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers active pharmaceutical ingredients (API) products, including acyclovir, amodiaquine, artemether, artesunate, bisoprolol fumarate, chloroquine phosphate, dihydroartemisinin, dolutegravir sodium, efavirenz, emtricitabine, etodolac, furosemide, hydroxychloroquine sulphate, lumefantrine, nimesulide, nitrofurantoin anhydrous and monohydrate, olanzapine, primaquine and piperaqui... [Read more]

Industry Pharmaceutical Preparations
Founded 1972
Employees 480
Stock Exchange Bombay Stock Exchange
Ticker Symbol 532637
Full Company Profile

Financial Performance

Financial Statements